Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

ImageneBio, Inc.

NotesSupport
aboutterms

Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

ImageneBio, Inc.

CIK 0001835579IMA· quarter ending 2026-06-30
Shares outstanding
11,351,456
as of 2026-07-31 · 10-Q cover page, filed 2026-08-05
Held by 13F filers
6,234,663
54.9% of shares outstanding
Holders
35
-4 vs 2026-03-31 · 4 new, 8 exited
Value
$36.8M
shares +16.4% vs prior quarter

Share classes (cover page of the 10-Q filed 2026-08-05, as of 2026-07-31)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockIMA · NASDAQ11,351,4566,234,66354.9%3545175G207

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
45175G207COM356,234,66311,351,45654.9%$36.8M—13DGholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 1 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (35 of 35 · 45175G207)

change vs 2026-03-31
#FilerShares% of classValueChange
1BVF INC/IL1,110,0029.78%$6.5M—
2Blue Owl Capital Holdings LP917,6928.08%$5.4M-41,645 (-4.3%)
3ORBIMED ADVISORS LLC909,2698.01%$5.4M+530,713 (+140.2%)
4Cable Car Capital, LP781,5996.89%$4.6M+26,850 (+3.6%)
5Omega Fund Management, LLC455,3614.01%$2.7M—
6RTW INVESTMENTS, LP334,4452.95%$2.0M—
7VANGUARD CAPITAL MANAGEMENT LLC320,5182.82%$1.9M-4,637 (-1.4%)
8Trails Edge Capital Partners, LP282,0042.48%$1.7MNEW
9BML Capital Management, LLC200,7301.77%$1.2M—
10Monashee Investment Management LLC192,3441.69%$1.1MNEW
11BlackRock, Inc.135,0901.19%$797K+5,876 (+4.5%)
12RENAISSANCE TECHNOLOGIES LLC86,9300.77%$513K+5,234 (+6.4%)
13ADAGE CAPITAL PARTNERS GP, L.L.C.66,6660.59%$393K—
14CITADEL ADVISORS LLC55,6100.49%$328K-68,735 (-55.3%)
15GEODE CAPITAL MANAGEMENT, LLC53,5120.47%$316K-6,417 (-10.7%)
16NEA Management Company, LLC50,0050.44%$295K—
17NANO CAP NEW MILLENNIUM GROWTH FUND L P50,0000.44%$295K+20,000 (+66.7%)
18HSBC HOLDINGS PLC34,2280.30%$208K-656 (-1.9%)
19Sofinnova Investments, Inc.31,8840.28%$188K—
20VANGUARD FIDUCIARY TRUST CO27,4750.24%$162K+189 (+0.7%)
21Rangeley Capital, LLC20,0900.18%$119K-12,500 (-38.4%)
22TWO SIGMA INVESTMENTS, LP19,9000.18%$117KNEW
23Aldebaran Capital, LLC18,1240.16%$107K-442 (-2.4%)
24Shay Capital LLC18,0800.16%$107K-1,050 (-5.5%)
25MORGAN STANLEY16,6780.15%$98K-1,661 (-9.1%)
26GOLDMAN SACHS GROUP INC15,4850.14%$91K+4,027 (+35.1%)
27NORTHERN TRUST CORP11,2710.10%$66KNEW
28BARCLAYS PLC10,7970.10%$64K-162 (-1.5%)
29UBS Group AG6,8790.06%$41K+1,451 (+26.7%)
30Tower Research Capital LLC (TRC)6750.01%$4K-336 (-33.2%)
31Vanguard Global Advisers, LLC6020.01%$4K—
32Caitong International Asset Management Co., Ltd4640.00%$3K+462 (+23100.0%)
33NewEdge Advisors, LLC1600.00%$944—
34JPMORGAN CHASE & CO700.00%$425-223 (-76.1%)
35BNP PARIBAS FINANCIAL MARKETS240.00%$142—
Exited since 2026-03-31 (8 filers; largest 8 shown)
JACOBS LEVY EQUITY MANAGEMENT, INC−26,663
XTX Topco Ltd−15,112
HRT FINANCIAL LP−13,909
JANE STREET GROUP, LLC−13,210
PRELUDE CAPITAL MANAGEMENT, LLC−12,990
ROYAL BANK OF CANADA−1,000
CITIGROUP INC−224
WELLS FARGO & COMPANY/MN−41

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
BIOTECHNOLOGY VALUE FUND II LPSCHEDULE 13G/A2026-08-142026-06-30433,2693.8%
BVF PARTNERS L P/ILSCHEDULE 13G/A2026-08-142026-06-301,128,6479.9%
BVF GP HOLDINGS LLCSCHEDULE 13G/A2026-08-142026-06-301,045,1039.3%
BVF II GP LLCSCHEDULE 13G/A2026-08-142026-06-30433,2693.8%
Biotechnology Value Trading Fund OS LPSCHEDULE 13G/A2026-08-142026-06-3066,8080.6%
LAMPERT MARK NSCHEDULE 13G/A2026-08-142026-06-301,128,6479.9%
BVF INC/ILSCHEDULE 13G/A2026-08-142026-06-301,128,6479.9%
BIOTECHNOLOGY VALUE FUND L PSCHEDULE 13G/A2026-08-142026-06-30611,8345.4%
BVF Partners OS Ltd.SCHEDULE 13G/A2026-08-142026-06-3066,8080.6%
BVF I GP LLCSCHEDULE 13G/A2026-08-142026-06-30611,8345.4%
Blue Owl Capital Holdings LPSCHEDULE 13G/A2026-05-142026-03-31959,3378.51%
OrbiMed Genesis GP LLCSCHEDULE 13D/A2026-04-292026-04-14405,3803.6%
ORBIMED ADVISORS LLCSCHEDULE 13D/A2026-04-292026-04-141,495,04513.1%
ORBIMED CAPITAL GP VI LLCSCHEDULE 13D/A2026-04-292026-04-141,089,6659.6%
ORBIMED CAPITAL LLCSCHEDULE 13D/A2026-04-292026-04-14135,5161.2%
Omega Fund VI GP, L.P.SCHEDULE 13D2026-04-212026-04-14935,8438.4%
Ortav YehudaiSCHEDULE 13G2026-04-212026-04-141,176,4729.9%
Trails Edge Capital Partners, LPSCHEDULE 13G2026-04-212026-04-141,176,4729.9%
Trails Edge Biotechnology Master Fund, LPSCHEDULE 13G2026-04-212026-04-141,176,4729.9%
Otello StampacchiaSCHEDULE 13D2026-04-212026-04-14936,2228.4%
Omega Fund VI GP Manager, Ltd.SCHEDULE 13D2026-04-212026-04-14935,8438.4%
Claudio NessiSCHEDULE 13D2026-04-212026-04-14935,8438.4%
Omega Fund VI, L.P.SCHEDULE 13D2026-04-212026-04-14935,8438.4%
David KroinSCHEDULE 13G/A2026-02-132025-12-3100%
Deep Track Capital, LPSCHEDULE 13G/A2026-02-132025-12-3100%
Deep Track Biotechnology Master Fund, Ltd.SCHEDULE 13G/A2026-02-132025-12-3100%
Funicular Funds, LPSCHEDULE 13G2026-01-062025-12-29643,9335.8%
Ma-Weaver JacobSCHEDULE 13G2026-01-062025-12-29643,9335.8%
Cable Car Capital, LPSCHEDULE 13G2026-01-062025-12-29643,9335.8%
Atlas Venture Associates XI, L.P.SCHEDULE 13D/A2025-07-292025-07-25103,4940.9%
Atlas Venture Associates Opportunity I, LLCSCHEDULE 13D/A2025-07-292025-07-2572,8850.6%
ATLAS VENTURE ASSOCIATES X, L.P.SCHEDULE 13D/A2025-07-292025-07-25241,8002.1%
Atlas Venture Associates X, LLCSCHEDULE 13D/A2025-07-292025-07-25241,8002.1%
Atlas Venture Associates XI, LLCSCHEDULE 13D/A2025-07-292025-07-25103,4940.9%
Atlas Venture Associates Opportunity I, L.P.SCHEDULE 13D/A2025-07-292025-07-2572,8850.6%
Atlas Venture Fund XI, L.P.SCHEDULE 13D/A2025-07-292025-07-25103,4940.9%
Atlas Venture Fund X, L.P.SCHEDULE 13D/A2025-07-292025-07-25241,8002.1%
Atlas Venture Opportunity Fund I, L.P.SCHEDULE 13D/A2025-07-292025-07-2572,8850.6%
Leonard Braden MichaelSCHEDULE 13D/A2025-07-282025-07-25220,8321.9%
BML Investment Partners, L.P.SCHEDULE 13D/A2025-07-282025-07-25215,8321.9%
GILEAD SCIENCES INCSCHEDULE 13G/A2025-02-132024-12-311,521,3123.6%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.